Related Experiment Videos
Atypical reginal vasculitis associated with ticlopidine hydrochloridine use
A Barak1, L S Morse, I R Schwab
1Department of Ophthalmology, University of California-Davis, Sacramento, California 95817, USA.
American Journal of Ophthalmology
|June 14, 2000
Summary
Retinal vasculitis can occur shortly after starting ticlopidine hydrochloride. Discontinuing this medication led to symptom resolution in two patients, suggesting a drug-related side effect.
Area of Science:
- Ophthalmology
- Pharmacology
- Toxicology
Background:
- Ticlopidine hydrochloride is an antiplatelet medication.
- Retinal vasculitis is inflammation of blood vessels in the retina.
Observation:
- Two patients developed retinal vasculitis within weeks of initiating ticlopidine hydrochloride therapy.
- Symptoms included visual disturbances like spots, floaters, and flashes, and decreased visual acuity.
Findings:
- Both patients experienced complete resolution of retinal vasculitis after discontinuing ticlopidine hydrochloride.
- The temporal association and symptom resolution strongly suggest ticlopidine hydrochloride as the causative agent.
Implications:
- This case series highlights a potential drug-induced side effect of ticlopidine hydrochloride.
- Early recognition and cessation of ticlopidine hydrochloride are crucial for managing this complication.